Product NDC: | 66993-712 |
Proprietary Name: | Mirtazapine |
Non Proprietary Name: | Mirtazapine |
Active Ingredient(s): | 45 mg/1 & nbsp; Mirtazapine |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 66993-712 |
Labeler Name: | Prasco Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021208 |
Marketing Category: | NDA AUTHORIZED GENERIC |
Start Marketing Date: | 20010112 |
Package NDC: | 66993-712-30 |
Package Description: | 5 BLISTER PACK in 1 BOX (66993-712-30) > 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
NDC Code | 66993-712-30 |
Proprietary Name | Mirtazapine |
Package Description | 5 BLISTER PACK in 1 BOX (66993-712-30) > 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
Product NDC | 66993-712 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Mirtazapine |
Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
Route Name | ORAL |
Start Marketing Date | 20010112 |
Marketing Category Name | NDA AUTHORIZED GENERIC |
Labeler Name | Prasco Laboratories |
Substance Name | MIRTAZAPINE |
Strength Number | 45 |
Strength Unit | mg/1 |
Pharmaceutical Classes |